MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
Akerna Corp. Accounts Payables 2011-2026 | KERN
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Akerna Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.51 M | 2.23 M | 1.42 M | 1.94 M | 514 K | 1.32 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.51 M | 514 K | 2.16 M |
Quarterly Accounts Payables Akerna Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 8.64 M | 6.86 M | 5.51 M | 5.76 M | 3.88 M | - | 2.23 M | 1.7 M | 1.75 M | 1.76 M | 1.51 M | 1.27 M | 3.79 M | 3.07 M | 1.94 M | 1.81 M | 1.13 M | 496 K | 514 K | 514 K | 514 K | 514 K | 1.67 M | 1.6 M | 1.32 M | 1.32 M | - | - | 550 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.64 M | 496 K | 2.37 M |
Accounts Payables of other stocks in the Health information services industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
7.39 M | - | 0.29 % | $ 206 M |  USA |
 |
Change Healthcare
CHNG
|
104 M | - | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
330 M | - | - | $ 27.9 B | USA |
 |
American Well Corporation
AMWL
|
1.65 M | $ 5.63 | -2.26 % | $ 90.3 M | USA |
 |
Computer Programs and Systems
CPSI
|
10.1 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
442 M | - | - | $ 2.94 B | USA |
 |
HealthStream
HSTM
|
6.63 M | $ 21.23 | 1.24 % | $ 645 M | USA |
 |
iCAD
ICAD
|
1.11 M | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
57.2 M | $ 2.27 | 0.89 % | $ 213 M | USA |
 |
NextGen Healthcare
NXGN
|
11.4 M | - | - | $ 1.6 B | USA |
 |
Omnicell
OMCL
|
51.8 M | $ 34.94 | 1.39 % | $ 1.61 B | USA |
 |
1Life Healthcare
ONEM
|
18.7 M | - | - | $ 3.37 B | USA |
 |
OptimizeRx Corporation
OPRX
|
2.23 M | $ 7.18 | 5.9 % | $ 123 M | USA |
 |
MTBC
MTBC
|
6.94 M | - | -0.58 % | $ 51.7 M | USA |
 |
Phreesia
PHR
|
8.48 M | $ 11.28 | - | $ 615 M | USA |
 |
Premier
PINC
|
19.6 M | - | - | $ 2.33 B | USA |
 |
GoodRx Holdings
GDRX
|
14.1 M | $ 2.06 | 0.98 % | $ 795 M | USA |
 |
Schrödinger
SDGR
|
11.5 M | $ 11.4 | -1.47 % | $ 837 M | USA |
 |
Signify Health
SGFY
|
84.1 M | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
17.7 M | - | - | $ 3.81 B | USA |
 |
Zhongchao
ZCMD
|
535 K | $ 1.8 | -0.55 % | $ 9.37 M |  China |
 |
Streamline Health Solutions
STRM
|
1.54 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
48 M | $ 5.57 | 2.77 % | $ 982 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
16.8 M | - | -10.39 % | $ 886 M | USA |
 |
10x Genomics
TXG
|
15.7 M | $ 20.91 | 5.55 % | $ 2.45 B | USA |
 |
Health Catalyst
HCAT
|
9.36 M | $ 1.1 | 0.46 % | $ 76.9 M | USA |
 |
NantHealth
NH
|
10.4 M | - | -46.64 % | $ 10.4 M | USA |
 |
HealthEquity
HQY
|
12.2 M | $ 82.47 | 0.45 % | $ 7.1 B | USA |
 |
SCWorx Corp.
WORX
|
600 K | $ 0.13 | 1.5 % | $ 190 K | USA |
 |
Tabula Rasa HealthCare
TRHC
|
19.5 M | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
95.1 M | $ 17.75 | -1.66 % | $ 1.52 B | USA |
 |
Veeva Systems
VEEV
|
37.6 M | $ 178.11 | -0.56 % | $ 29.2 B | USA |